Bone sialoprotein (BSP) is a prominent mineral-associated protein in the extracellular matrix of bone that has been implicated in the metastatic activity of cancer cells. Forskolin (FSK) is a labdanediterpene that is produced by the Indian Coleus plant. FSK elevates cyclic AMP (cAMP) via adenylate cyclase activated protein kinase A (PKA), and it is widely used to study cAMP regulation of cell processes.
Introduction
Breast cancer cells are among the few human cancer cell types that exhibit the highest affinity for bone. The majority of patients with advanced breast cancer have evidence of skeletal metastases (1) . Little is known about the molecular mechanisms responsible for breast cancer cells osteotropism, the phenomenon that defines the strong affinity of these cells for bone. A possible explanation could be provided by recent finding that breast cancer cells express high amounts of bone sialoprotein (BSP) (2) . BSP is a highly phosphorylated and sulfated glycoprotein which is a major component of the mineralized bone and cementum matrix (3, 4) . It has highlynegatively charged characteristics, BSP can sequestercalcium ions through conserving polyglutamate regions, which have hydroxyapatite crystal nucleation potential(5).
BSP mediates the attachment and activationof osteoclasts through the RGD motif (6, 7) and can facilitate attachment of normal bone or cancer cells to mineralized tissue surfaces (3) (4) (5) (6) (7) . BSP and osteopontin (OPN) can bind to factor H and protect cells from complement-mediated cell lysis, which may be important for cancer cell survival (8) .
BSP is expressed by mature osteoblasts, osteoclasts and hypertrophic chondrocytes (9, 10) , and is also detectable in breast (1, 2) , lung (11) and prostate cancers (12, 13) , which could metastasized to bone, suggesting that BSP may play a role in the pathogenesis of bone metastases (14) . The BSP gene promoters have been cloned and partially characterized (15) (16) (17) (18) . Rat BSP gene promoter have an inverted TATA box (−24 to −19) (19) , an inverted CCAAT box (−50 to −46) which is required for basal transcription (20, 21) . In addition, a cyclic AMP (cAMP) response element (CRE; −75 to −68) (22-24), a fibroblast growth factor 2 (FGF2) response element (FRE; −92 to −85) (22, (25) (26) (27) , a runt-related transcription factor 2 (Runx2) binding site (−84 to −79)(28), a pituitary-specific transcription factor-1 (Pit-1) motif (−111 to −105) (29), a homeodomain protein binding site (HOX; −199 to −192) (26, 30) , a transforming growth factor-β (TGF-β) activation element (TAE; −499 to −485)(31) and a glucocorticoid response element (GRE; −931 to −906) overlapping an activator protein 1 site (AP1; −921 to −915) (32, 33) have also been characterized. We have previously reported FGF2 and cAMP synergistically regulate BSP gene expression (28) .
Forskolin (FSK) is a product of an Indian Coleus plant which elevates cAMP via adenylate cyclase activated protein kinase A (PKA) pathway. Therefore, to elucidate the molecular mechanism of the FSK regulate BSP gene transcription, we have analyzed the effects of FSK on the expression of BSP in human breast cancer MCF7 cells. 
Materials and Methods

Materials
Reverse transcription polymerase chain reaction (RT-PCR)
Total RNA (1 μg) was extracted with the guanidium thiocyanate described previously (31) and used as a template for cDNA synthesis. 
Statistical analysis
Quadruplicate or triplicate samples were analyzed for each experiment, and experiments were replicated to ensure the consistency of the responses to the drugs.
Significant differences between control and treatment groups were determined using the one-way ANOVA.
Results
Stimulation of BSP, Runx2 and Osterix mRNA levels in MCF7 Cells
To study the regulation of BSP expression by FSK in breast cancer cells, we performed RT-PCR using total RNA extracted from MCF7 cells. Since Runx2 and Osterix are considered master genes for osteogenesis, the effects of FSK on their expression were also analyzed by RT-PCR. Results of RT-PCR showed that FSK (1 μM) increased BSP mRNA level at 12 h and reached a maximum at 24 h. The Runx2 mRNA level was increased at 3 h, decreased at 6 h, and increased again at 12 and 24 h. The Osterix mRNA level increased at 6 h and reached maximal at 12 h (Fig. 1) .
Transient transfection analysis
Transient transfection of chimeric constructs encompassing different regions of the rat BSP gene promoter that ligated to a luciferase reporter gene (pLUC3~6) were performed in MCF7 cells (Fig. 2) . The results of the transfection assays indicated an increase in transcription after 12 h with constructs pLUC3 (−116~+60), pLUC4 (−425~+60), pLUC5 (−801~+60) and pLUC6 (−938~+60) following treatment with 1 μM of FSK (Fig.   2 ). Within the pLUC3 luciferase construct, an inverted TATA and CCAAT box, a CRE, a Runx2, a FRE and a Pit-1 motif are present ( Fig. 3) . To confirm the functional elements, we performed site-specific mutation analyses.
Two base pair mutation in CRE, Runx2 and FRE in pLUC3
abolished the FSK induced BSP promoter activities, whereas mutation in CCAAT had no effect (Fig. 4) . The results suggested that CRE, Runx2 and FRE are functional response elements for FSK. tumors express BSP (2, (11) (12) (13) (14) 36) , and FSK increased BSP and Runx2 mRNA and protein levels in prostate cancer cells (13) . Osteocalcin (OC) and BSP expression is coordinated and regulated through cAMP-dependent PKA signaling, which may define the molecular basis of the osteomimicry exhibited by prostate cancer cells (37) .
Gel mobility shift assays
RT-PCR results showed that FSK treatment of MCF7
breast cancer cells increased the steady-state levels of BSP, (−938~+60)) were increased by FSK (Fig. 2) . Insertion of two base pair mutations in CRE, Runx2 or FRE sites in pLUC3 constructs abolished the FSK induced BSP promoter activities (Fig. 4) . The results suggest that CRE, Runx2 and FRE are functional response elements for FSK. Results of gel shift assays showed that proteins from nuclear extracts that formed complexes with the CRE and FRE were increasedby FSK (Fig. 5 ). Previously, a FRE (GGTGAGA A) was identified in the rat BSP proximal gene promoter that was juxtaposed to a putative Runx2 binding site (CCCACA) ( Fig. 3) Breast cancer has become a serious health concern for women. It most commonly metastasizes to the lymph nodes and bone and causes significant morbidity in women with an advanced disease (1, 2, 14) . Although there is little understanding of the molecular mechanisms responsible for bone metastasis in breast cancer, previous research found that noncollageous bone matrix proteins, such as OC, OPN and BSP, are expressed at high levels in advanced bone metastatic breast and prostate cancer cells. However, normal breasts and prostates do not express bone matrix proteins (12, 14) . These observations led us to focus specifically on the regulation of BSP expressions in breast cancer cells. BSP and OC expressions in prostate cancer cells are regulated by PKA signaling (37) . Therefore, in this study, we used FSK, an activator of adenylate cyclase, which has been extensively used to stimulate the cAMP-PKA metastatic breast cancer cells (39) . We previously reported that FRE binding proteins in Saos2 osteoblast-like cells were Runx2, Dlx5 and Smad1, and that anti-Smad1 antibody coprecipitated Smad1 and Runx2 (26) . It is possible that Runx2 may interact with CRE, because CRE is located adjacent to FRE in the proximal promoter of the rat BSP gene. CREB1
and AP1 transcription factors JunD and Fra2 regulated BSP gene expression in human breast cancer cells (40) . Osterix is a C2H2-type zinc finger transcription factor from the SP gene family and a putative master regulator of bone cell differentiation. Osterix-deficient mice display an absence of bone due to arrested osteoblast differentiation (41) . In this study, we showed that FSK induced Osterix mRNA levels in MCF7 human breast cancer cells (Fig. 1) . The putative
Osterix response element is a G/C-rich sequence; although, we could not identify the Osterix binding site yet. Further study is necessary to elucidate the regulatory element in the rat and human BSP gene promoter.
In this study, we demonstrate that FSK-induced BSP transcription in human breast cancer cells was under the control of transcription factors interacted with CRE, Runx2 and FRE elements. In conclusion, our study suggests that the cAMP-PKA signaling pathway inhibitor may have a potential to be a therapeutic agent for breast cancer. 12) . CCAAT-and Pit-1-protein complexes did not change after stimulation by FSK (lanes 1-4, 13-16 ). DNAprotein complexes were separated on a 5% polyacrylamide gel in a low-ionic-strength Tris-borate buffer, dried under a vacuum, and exposed to an imaging plate for quantitation using an imaging analyzer.
